Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

US Fed Meeting: Jerome Powell-led FOMC Cuts Key Interest Rates To 3.50%-3.75% Amid Elevated...

US Fed Meeting: Jerome Powell-led FOMC Cuts Key Interest Rates To 3.50%-3.75% Amid Elevated...

Elon Musk Reaffirms Starlink’s Commitment To India As Company Officials Meet Union Minister...

Elon Musk Reaffirms Starlink’s Commitment To India As Company Officials Meet Union Minister...

Adani Electricity Wins All 15 ‘Gold’ Awards At QCFI’s 39th Annual Quality Convention

Adani Electricity Wins All 15 ‘Gold’ Awards At QCFI’s 39th Annual Quality Convention

Akasa Air Inducts 31st Boeing 737 MAX; To Receive Delivery Of 195 Aircraft Over Next 7 Years

Akasa Air Inducts 31st Boeing 737 MAX; To Receive Delivery Of 195 Aircraft Over Next 7 Years

Groww Parent’s Stock Falls 5 Per Cent As Lock-In Period Ends; 14.92 Crore Shares Hit Market

Groww Parent’s Stock Falls 5 Per Cent As Lock-In Period Ends; 14.92 Crore Shares Hit Market